{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:24:44Z","timestamp":1750098284190},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Diane and Robert Roskamp and the Roskamp Foundation"},{"name":"NIH-funded University of Washington STD & AIDS Research Training","award":["Grant, T32AI007410"],"award-info":[{"award-number":["Grant, T32AI007410"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.biochi.2015.08.009","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T03:17:04Z","timestamp":1440040624000},"page":"90-103","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["HIV-1 protease substrate-groove: Role in substrate recognition and inhibitor resistance"],"prefix":"10.1016","volume":"118","author":[{"given":"Gary S.","family":"Laco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2015.08.009_bib1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.6601823","article-title":"Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Gallo","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.biochi.2015.08.009_bib2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barre-Sinoussi","year":"1983","journal-title":"Science"},{"year":"2012","series-title":"World AIDS Day Report: Results; 2012","author":"UNAIDS","key":"10.1016\/j.biochi.2015.08.009_bib3"},{"year":"2013","series-title":"Report on the Global AIDS Epidemic","author":"UNAIDS","key":"10.1016\/j.biochi.2015.08.009_bib4"},{"key":"10.1016\/j.biochi.2015.08.009_bib5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/294268a0","article-title":"Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia","volume":"294","author":"Poiesz","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2015.08.009_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2012.09.028","article-title":"HTLV-1: persistence and pathogenesis","volume":"435","author":"Cook","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.biochi.2015.08.009_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11912-013-0332-6","article-title":"Therapeutic options for adult T-cell leukemia\/lymphoma","volume":"15","author":"Marcais","year":"2013","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.biochi.2015.08.009_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/v2010147","article-title":"Comparative studies on retroviral proteases: substrate specificity","volume":"2","author":"Tozser","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.biochi.2015.08.009_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/331280a0","article-title":"Characterization of ribosomal frameshifting in HIV-1 gag-pol expression","volume":"331","author":"Jacks","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2015.08.009_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.2183354","article-title":"Rational design of peptide-based HIV proteinase inhibitors","volume":"248","author":"Roberts","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.biochi.2015.08.009_bib11","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.1073\/pnas.86.24.9752","article-title":"Inhibition of human immunodeficiency virus 1 protease in\u00a0vitro: rational design of substrate analogue inhibitors","volume":"86","author":"Dreyer","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2015.08.009_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/343090a0","article-title":"Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues","volume":"343","author":"Meek","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2015.08.009_bib13","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1073\/pnas.85.13.4686","article-title":"Active human immunodeficiency virus protease is required for viral infectivity","volume":"85","author":"Kohl","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2015.08.009_bib14","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1128\/JVI.63.6.2550-2556.1989","article-title":"Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity","volume":"63","author":"Peng","year":"1989","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib15","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/JVI.65.2.922-930.1991","article-title":"Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein","volume":"65","author":"Tritch","year":"1991","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib16","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JVI.72.4.2846-2854.1998","article-title":"Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites","volume":"72","author":"Wiegers","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib17","doi-asserted-by":"crossref","first-page":"29692","DOI":"10.1074\/jbc.M109.027144","article-title":"HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity","volume":"284","author":"Muller","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2015.08.009_bib18","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1128\/JVI.00317-09","article-title":"A\u00a0strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle","volume":"83","author":"Lee","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0969-2126(02)00720-7","article-title":"Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes","volume":"10","author":"Prabu-Jeyabalan","year":"2002","journal-title":"Structure"},{"key":"10.1016\/j.biochi.2015.08.009_bib20","doi-asserted-by":"crossref","first-page":"13279","DOI":"10.1074\/jbc.M112.339374","article-title":"Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease","volume":"287","author":"Lee","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2015.08.009_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0092-8674(88)90199-7","article-title":"Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease","volume":"54","author":"Schneider","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2015.08.009_bib22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1126\/science.2548279","article-title":"Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease","volume":"245","author":"Wlodawer","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.biochi.2015.08.009_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/342299a0","article-title":"X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes","volume":"342","author":"Lapatto","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2015.08.009_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/337615a0","article-title":"Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1","volume":"337","author":"Navia","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2015.08.009_bib25","doi-asserted-by":"crossref","first-page":"10696","DOI":"10.1021\/bi9707436","article-title":"Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor","volume":"36","author":"Laco","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2015.08.009_bib26","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.2686029","article-title":"Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution","volume":"246","author":"Miller","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.biochi.2015.08.009_bib27","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1073\/pnas.87.22.8805","article-title":"X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor","volume":"87","author":"Swain","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2015.08.009_bib28","doi-asserted-by":"crossref","first-page":"18332","DOI":"10.1073\/pnas.0509335102","article-title":"Crystal structure of human T cell leukemia virus protease, a novel target for anticancer drug design","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2015.08.009_bib29","doi-asserted-by":"crossref","first-page":"14539","DOI":"10.1016\/S0021-9258(18)98720-X","article-title":"Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid","volume":"266","author":"Pettit","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2015.08.009_bib30","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1073\/pnas.85.12.4185","article-title":"Synthetic peptides as substrates and inhibitors of a retroviral protease","volume":"85","author":"Kotler","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2015.08.009_bib31","doi-asserted-by":"crossref","first-page":"17905","DOI":"10.1016\/S0021-9258(19)81300-5","article-title":"Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease","volume":"263","author":"Billich","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2015.08.009_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0006-291X(88)80839-8","article-title":"HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins","volume":"156","author":"Darke","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2015.08.009_bib33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1073\/pnas.86.3.807","article-title":"Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides","volume":"86","author":"Krausslich","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2015.08.009_bib34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0006-291X(89)90008-9","article-title":"Peptide substrates and inhibitors of the HIV-1 protease","volume":"159","author":"Moore","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2015.08.009_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-5793(91)80362-7","article-title":"Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins","volume":"281","author":"Tozser","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biochi.2015.08.009_bib36","doi-asserted-by":"crossref","first-page":"31957","DOI":"10.1074\/jbc.271.50.31957","article-title":"Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity","volume":"271","author":"Schock","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2015.08.009_bib37","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1021\/bi971072e","article-title":"Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in\u00a0vivo","volume":"36","author":"Ermolieff","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2015.08.009_bib38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/aid.1989.5.577","article-title":"Cleavage of HIV-1 gag polyprotein synthesized in\u00a0vitro: sequential cleavage by the viral protease","volume":"5","author":"Erickson-Viitanen","year":"1989","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.biochi.2015.08.009_bib39","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1128\/JVI.68.12.8017-8027.1994","article-title":"The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions","volume":"68","author":"Pettit","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib40","doi-asserted-by":"crossref","first-page":"10226","DOI":"10.1128\/JVI.76.20.10226-10233.2002","article-title":"Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease","volume":"76","author":"Pettit","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1742-4690-2-66","article-title":"Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates","volume":"2","author":"Pettit","year":"2005","journal-title":"Retrovirology"},{"key":"10.1016\/j.biochi.2015.08.009_bib42","first-page":"537","article-title":"Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein","volume":"9","author":"Tang","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.biochi.2015.08.009_bib43","doi-asserted-by":"crossref","first-page":"e24314","DOI":"10.1371\/journal.pone.0024314","article-title":"Evaluation of two models for human topoisomerase I interaction with dsDNA and camptothecin derivatives","volume":"6","author":"Laco","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2015.08.009_bib44","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/cb300191k","article-title":"Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease","volume":"7","author":"King","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biochi.2015.08.009_bib45","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jmb.2007.09.083","article-title":"Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants","volume":"374","author":"Kozisek","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2015.08.009_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/biology1010081","article-title":"Higher desolvation energy reduces molecular recognition in multi-drug resistant HIV-1 protease","volume":"1","author":"Wang","year":"2012","journal-title":"Biol. Basel"},{"key":"10.1016\/j.biochi.2015.08.009_bib47","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/nar\/gkn072","article-title":"PROMALS3D: a tool for multiple protein sequence and structure alignments","volume":"36","author":"Pei","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biochi.2015.08.009_bib48","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.chembiol.2013.07.014","article-title":"Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance","volume":"20","author":"Nalam","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biochi.2015.08.009_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2003.10.047","article-title":"Visible fluorescent detection of proteins in polyacrylamide gels without staining","volume":"326","author":"Ladner","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biochi.2015.08.009_bib50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"Rhee","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.biochi.2015.08.009_bib51","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/505356","article-title":"Rationale and uses of a public HIV drug-resistance database","volume":"194","author":"Shafer","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.biochi.2015.08.009_bib52","first-page":"6","article-title":"Update of the drug resistance mutations in HIV-1: March 2013","volume":"21","author":"Johnson","year":"2013","journal-title":"Top. Antivir. Med."},{"key":"10.1016\/j.biochi.2015.08.009_bib53","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1073\/pnas.91.12.5597","article-title":"Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease","volume":"91","author":"Kaplan","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2015.08.009_bib54","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/JVI.68.3.2016-2020.1994","article-title":"Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor","volume":"68","author":"Ho","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib55","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1128\/JVI.69.9.5228-5235.1995","article-title":"In\u00a0vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease","volume":"69","author":"Partaledis","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib56","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1021\/bi00029a002","article-title":"Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure","volume":"34","author":"Gulnik","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2015.08.009_bib57","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1128\/JVI.69.2.701-706.1995","article-title":"Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor","volume":"69","author":"Markowitz","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib58","doi-asserted-by":"crossref","first-page":"21433","DOI":"10.1074\/jbc.270.37.21433","article-title":"Three-dimensional structure of a mutant HIV-1 protease displaying cross-resistance to all protease inhibitors in clinical trials","volume":"270","author":"Chen","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2015.08.009_bib59","doi-asserted-by":"crossref","first-page":"17979","DOI":"10.1074\/jbc.271.30.17979","article-title":"Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants","volume":"271","author":"Pazhanisamy","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2015.08.009_bib60","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JVI.71.2.1089-1096.1997","article-title":"Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors","volume":"71","author":"Croteau","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib61","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1128\/JVI.72.4.3300-3306.1998","article-title":"Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in\u00a0vivo","volume":"72","author":"Zennou","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib62","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/JVI.73.4.3455-3459.1999","article-title":"Effects of human immunodeficiency virus type 1 resistance to protease inhibitors on reverse transcriptase processing, activity, and drug sensitivity","volume":"73","author":"de la Carriere","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib63","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1097\/00002030-199912030-00006","article-title":"Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy","volume":"13","author":"Nijhuis","year":"1999","journal-title":"Aids"},{"key":"10.1016\/j.biochi.2015.08.009_bib64","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/JVI.73.5.3744-3752.1999","article-title":"Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1","volume":"73","author":"Martinez-Picado","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib65","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1128\/JVI.74.18.8524-8531.2000","article-title":"Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug","volume":"74","author":"Mammano","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib66","doi-asserted-by":"crossref","first-page":"8659","DOI":"10.1128\/JVI.76.17.8659-8666.2002","volume":"76","author":"Resch","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib67","doi-asserted-by":"crossref","first-page":"12446","DOI":"10.1128\/JVI.78.22.12446-12454.2004","article-title":"Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease","volume":"78","author":"Prabu-Jeyabalan","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib68","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jmb.2011.03.038","article-title":"Accessory mutations maintain stability in drug-resistant HIV-1 protease","volume":"410","author":"Chang","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2015.08.009_bib69","article-title":"Agouron protease inhibitor AG1343: activity reported","volume":"6","author":"James","year":"1995","journal-title":"AIDS Treat. News"},{"key":"10.1016\/j.biochi.2015.08.009_bib70","first-page":"1","article-title":"Nelfinavir (Viracept) approved: fourth protease inhibitor available","author":"James","year":"1997","journal-title":"AIDS Treat. News"},{"key":"10.1016\/j.biochi.2015.08.009_bib71","first-page":"95","article-title":"From amprenavir to GW433908","volume":"6","author":"Gatell","year":"2001","journal-title":"J.\u00a0HIV Ther."},{"key":"10.1016\/j.biochi.2015.08.009_bib72","first-page":"384","article-title":"Fosamprenavir. Vertex pharmaceuticals\/GlaxoSmithKline","volume":"3","author":"Corbett","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.biochi.2015.08.009_bib73","doi-asserted-by":"crossref","first-page":"17514","DOI":"10.1021\/bi982004a","article-title":"Substrates and inhibitors of human T-cell leukemia virus type I protease","volume":"37","author":"Ding","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2015.08.009_bib74","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1089\/aid.1998.14.1007","article-title":"HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells","volume":"14","author":"Pettit","year":"1998","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.biochi.2015.08.009_bib75","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1074\/jbc.274.10.6660","article-title":"Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase","volume":"274","author":"Louis","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2015.08.009_bib76","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1046\/j.1432-1327.2000.01714.x","article-title":"Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases","volume":"267","author":"Tozser","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.biochi.2015.08.009_bib77","doi-asserted-by":"crossref","first-page":"12933","DOI":"10.1021\/bi9612733","article-title":"Three-dimensional structures of HIV-1 and SIV protease product complexes","volume":"35","author":"Rose","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2015.08.009_bib78","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/pro.5560050802","article-title":"Structure of equine infectious anemia virus proteinase complexed with an inhibitor","volume":"5","author":"Gustchina","year":"1996","journal-title":"Protein Sci."},{"key":"10.1016\/j.biochi.2015.08.009_bib79","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1110\/ps.8.8.1702","article-title":"Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pH","volume":"8","author":"Xie","year":"1999","journal-title":"Protein Sci."},{"key":"10.1016\/j.biochi.2015.08.009_bib80","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1021\/bi027019u","article-title":"A\u00a0major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance","volume":"42","author":"Muzammil","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2015.08.009_bib81","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jmb.2006.07.073","article-title":"Suppression of HIV-1 protease inhibitor resistance by phosphonate-mediated solvent anchoring","volume":"363","author":"Cihlar","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2015.08.009_bib82","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/COH.0b013e328313911d","article-title":"Approaches to the design of HIV protease inhibitors with improved resistance profiles","volume":"3","author":"Gulnik","year":"2008","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.biochi.2015.08.009_bib83","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1021\/ar7001232","article-title":"Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance","volume":"41","author":"Ghosh","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biochi.2015.08.009_bib84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2009.10.003","article-title":"Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance","volume":"85","author":"Wensing","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biochi.2015.08.009_bib85","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/ct9004678","article-title":"Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV","volume":"6","author":"Cai","year":"2010","journal-title":"J.\u00a0Chem. Theory Comput."},{"key":"10.1016\/j.biochi.2015.08.009_bib86","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/j.1742-4658.2010.07771.x","article-title":"Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters","volume":"277","author":"Shen","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.biochi.2015.08.009_bib87","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1016\/S0021-9258(18)71628-1","article-title":"Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in Escherichia coli","volume":"264","author":"Muller","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2015.08.009_bib88","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/JVI.71.5.3507-3514.1997","article-title":"Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase","volume":"71","author":"Engelman","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib89","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/AAC.48.2.444-452.2004","article-title":"Gag non-cleavage site mutations contribute to full recovery of viral fitness in protease inhibitor-resistant human immunodeficiency virus type 1","volume":"48","author":"Myint","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biochi.2015.08.009_bib90","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1128\/JVI.02356-08","article-title":"Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1","volume":"83","author":"Parry","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2015.08.009_bib91","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3851\/IMP1812","article-title":"Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy","volume":"16","author":"McKinnon","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biochi.2015.08.009_bib92","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1742-4690-9-63","article-title":"Human Immunodeficiency Virus Gag and protease: partners in resistance","volume":"9","author":"Fun","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.biochi.2015.08.009_bib93","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/prot.340060205","article-title":"Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli","volume":"6","author":"Strickler","year":"1989","journal-title":"Proteins"},{"key":"10.1016\/j.biochi.2015.08.009_bib94","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.biochi.2015.08.009_bib95","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Goncalves","year":"2010","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908415002564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908415002564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T14:00:59Z","timestamp":1653055259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908415002564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":95,"alternative-id":["S0300908415002564"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2015.08.009","relation":{},"ISSN":["0300-9084"],"issn-type":[{"type":"print","value":"0300-9084"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 protease substrate-groove: Role in substrate recognition and inhibitor resistance","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2015.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}